Literature DB >> 2161425

The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers.

M A MacKenzie1, W H Hoefnagels, R W Jansen, T J Benraad, P W Kloppenborg.   

Abstract

Based on studies in laboratory animals and on measurements of the urinary metabolites (allo)tetrahydrocortisol and tetrahydrocortisone in human volunteers it has been claimed that liquorice-induced mineralocorticoid excess is caused by a unique defect in the conversion of cortisol to cortisone. To further evaluate this hypothesis we have investigated the influence of glycyrrhetinic acid (GA), the mineralocorticoid-active constituent of liquorice, on plasma cortisol and cortisone in 10 healthy young normotensive volunteers. Pure GA (500 mg/day), administered orally from days 3-10 of the study, exerted pronounced mineralocorticoid activity. Ingestion of GA resulted in an elevated urinary excretion of free cortisol and virtually unchanged plasma cortisol levels in the presence of markedly decreased levels of both plasma cortisone and urinary free cortisone. These results provide direct clinical support for the hypothesis that GA induces an inhibition of the activity of 11 beta-dehydrogenase, resulting in a blockade in the conversion of cortisol to cortisone.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161425     DOI: 10.1210/jcem-70-6-1637

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Apparent mineralocorticoid excess syndromes.

Authors:  M Shimojo; P M Stewart
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

Review 2.  Anti-inflammatory glucocorticoid drugs: reflections after 60 years.

Authors:  Michael W Whitehouse
Journal:  Inflammopharmacology       Date:  2010-10-31       Impact factor: 4.473

3.  A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.

Authors:  H J L M Timmers; E M van Ginneken; P Wesseling; C G J Sweep; A R M M Hermus
Journal:  J Endocrinol Invest       Date:  2006-11       Impact factor: 4.256

Review 4.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  Inhibition of human complement by beta-glycyrrhetinic acid.

Authors:  B H Kroes; C J Beukelman; A J van den Berg; G J Wolbink; H van Dijk; R P Labadie
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

Review 6.  The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis.

Authors:  R Penninkilampi; E M Eslick; G D Eslick
Journal:  J Hum Hypertens       Date:  2017-06-29       Impact factor: 3.012

7.  11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension.

Authors:  Carmen Campino; Cristian A Carvajal; Javiera Cornejo; Betty San Martín; Oliviero Olivieri; Giancesare Guidi; Giovanni Faccini; Francesco Pasini; Javiera Sateler; Rene Baudrand; Lorena Mosso; Gareth I Owen; Alexis M Kalergis; Oslando Padilla; Carlos E Fardella
Journal:  Endocrine       Date:  2009-10-31       Impact factor: 3.633

8.  11-Beta Dehydrogenase Type 2 Activity Is Not Reduced in Treatment Resistant Hypertension.

Authors:  Lama Ghazi; Tanja Dudenbostel; Maria El Hachem; Mohammed Siddiqui; Chee Paul Lin; Suzanne Oparil; David A Calhoun
Journal:  Am J Hypertens       Date:  2017-05-01       Impact factor: 2.689

9.  Lozenge-Induced Hypermineralcorticoid State--A Unique Case of Licorice Lozenges Resulting in Hypertension and Hypokalemia.

Authors:  David W Dai; Ishita Singh; Jerome M Hershman
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-07-25       Impact factor: 3.738

10.  Herbal Medicine Containing Licorice May Be Contraindicated for a Patient with an HSD11B2 Mutation.

Authors:  Indra Sari Kusuma Harahap; Naoko Sasaki; Surini Yusoff; Myeong Jin Lee; Satoru Morikawa; Noriyuki Nishimura; Tomohiro Sasaki; Seiichiro Usuki; Midori Hirai; Mika Ohta; Yutaka Takaoka; Takashi Nishimoto; Hisahide Nishio
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.